rs200273960
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_182915.3(STEAP3):c.260A>G(p.Gln87Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000243 in 1,614,196 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_182915.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152210Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000183 AC: 46AN: 251148Hom.: 1 AF XY: 0.000206 AC XY: 28AN XY: 135750
GnomAD4 exome AF: 0.000248 AC: 363AN: 1461868Hom.: 1 Cov.: 31 AF XY: 0.000245 AC XY: 178AN XY: 727234
GnomAD4 genome AF: 0.000190 AC: 29AN: 152328Hom.: 0 Cov.: 33 AF XY: 0.000228 AC XY: 17AN XY: 74484
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.260A>G (p.Q87R) alteration is located in exon 3 (coding exon 2) of the STEAP3 gene. This alteration results from a A to G substitution at nucleotide position 260, causing the glutamine (Q) at amino acid position 87 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 77 of the STEAP3 protein (p.Gln77Arg). This variant is present in population databases (rs200273960, gnomAD 0.09%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with STEAP3-related conditions. ClinVar contains an entry for this variant (Variation ID: 2364119). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at